Selective laser trabeculoplasty for intraocular pressure elevation after intravitreal triamcinolone acetonide injection

Optometry and Vision Science

Volumn 83, Issue 7, 2006, Pages 421-425

  Pizzimenti, Joseph J ^a   Nickerson, Maritza M ^a   Pizzimenti, Claire E ^a   Kasten Aker, Ann G ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Diabetic macular edema; Intraocular pressure; Intravitreal injection; Selective laser trabeculoplasty; Steroid response; Triamcinolone acetonide

Indexed keywords

LASER APPLICATIONS; NEUROLOGY; PATIENT TREATMENT; SURGERY; SYRINGES;

DIABETIC MACULAR EDEMA; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTION; SELECTIVE LASER TRABECULOPLASTY; STEROID RESPONSE; TRIAMCINOLONE ACETONIDE;

DISEASES;

STEROID; TRIAMCINOLONE ACETONIDE;

ADULT; ARTICLE; CASE REPORT; DIABETIC MACULAR EDEMA; EYE INFLAMMATION; FILTERING OPERATION; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; LASER SURGERY; MALE; PRIORITY JOURNAL; TONOMETRY; TRABECULOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME;

DIABETIC RETINOPATHY; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INJECTIONS; INTRAOCULAR PRESSURE; LASER SURGERY; MACULAR EDEMA, CYSTOID; MALE; MIDDLE AGED; OCULAR HYPERTENSION; TRABECULECTOMY; TRIAMCINOLONE ACETONIDE; VITREOUS BODY;

EID: 33746660757     PISSN: 10405488     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.opx.0000225106.52653.72     Document Type: Article

References (24)

1. Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R. Intravitreal triamcinolone acetonide for exudative age related macular degeneration. Br J Ophthalmol 2003;87:462-8.
2. Ip MS, Gottlieb JL, Kahana A, Scott IU, Altaweel MM, Blodi BA, Gangnon RE, Puliafito CA. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion. Arch Ophthalmol 2004;122:1131-6.
3. Antcliff RJ, Spalton DJ, Stanford MR, Graham EM, Ffytche TJ, Marshall J. Intravitreal triamcinolone for uveitic cystoid macular edema: an optical coherence tomography study. Ophthalmology 2001;108:765-72.
4. Massin P, Audren F, Haouchine B, Erginay A, Bergmann JF, Benosman R, Caulin C, Gaudric A. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 2004;111:218-25.
5. Bui Quoc E, Bodaghi B, Adam R, Burtin T, Cassoux N, Dreifuss S, Fardeau C, LeHoang P. [Intraocular pressure elevation after subtenon injection of triamcinolone acetonide during uveitis.] J Fr Ophtalmol 2002;25:1048-56.
6. Karacorlu M, Ozdemir H, Karacorlu S, Alacali N. Regression of optic nerve head neovascularization in proliferative diabetic retinopathy after intravitreal triamcinolone. Regression of diabetic optic disc neovascularization after intravitreal triamcinolone. Int Ophthalmol 2004;25:113-6.
7. Jonas JB, Kreissig I, Degenring RF. Neovascular glaucoma treated by intravitreal triamcinolone acetonide. Acta Ophthalmol Scand 2003;81:540-1.
8. Jonas JB, Hayler JK, Panda-Jonas S. Intravitreal injection of crystalline cortisone as adjunctive treatment of proliferative vitreoretinopathy. Br J Ophthalmol 2000;84:1064-7.
9. Detry-Morel M, Escarmelle A, Hermans I. Refractory ocular hypertension secondary to intravitreal injection of triamcinolone acetonide. Bull Soc Belge Ophtalmol 2004;292:45-51.
10. Singh IP, Ahmad SI, Yeh D, Challa P, Herndon LW, Allingham RR, Lee PP. Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 2004;138:286-7.
11. Beer PM, Bakri SJ, Singh RJ, Liu W, Peters GB 3rd, Miller M. Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 2003;110:681-6.
12. Jonas JB, Degenring RF, Kreissig I, Akkoyun I, Kamppeter BA. Intraocular pressure elevation after intravitreal triamcinolone acetonide injection. Ophthalmology 2005;112:593-8.
13. Alward WL. Glaucoma. The Requisites in Ophthalmology Series. St. Louis: Mosby; 2000.
14. Latina MA, de Leon JM. Selective laser trabeculoplasty. Ophthalmol Clin North Am 2005;18:409-19.
15. Shaffer RN. Stereoscopic Manual of Gonioscopy. St. Louis: Mosby; 1962.
16. Jaanus SD. Anti-inflammatory drugs. In: Bartlett JD, Jaanus SD, eds. Clinical Ocular Pharmacology, 4th ed. Boston: Butterworth-Heinemann; 2001:153-92.
17. Wingate RJ, Beaumont PE. Intravitreal triamcinolone and elevated intraocular pressure. Aust N Z J Ophthalmol 1999;27:431-2.
18. Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology 1984;91:1-9.
19. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol 2003;121:57-61.
20. Polansky JR, Fauss DJ, Chen P, Chen H, Lutjen-Drecoll E, Johnson D, Kurtz RM, Ma ZD, Bloom E, Nguyen TD. Cellular pharmacology and molecular biology of the trabecular meshwork inducible glucocorticoid response gene product. Ophthalmologica 1997;211:126-39.
21. Johnson D, Gottanka J, Flugel C, Hoffmann F, Futa R, Lutjen-Drecoll E. Ultrastructural changes in the trabecular meshwork of human eyes treated with corticosteroids. Arch Ophthalmol 1997;115:375-83.
22. Wordinger RJ, Clark AF. Effects of glucocorticoids on the trabecular meshwork: towards a better understanding of glaucoma. Prog Ret Eye Res 1999;18:629-67.
23. Agrawal S, Agrawal J, Agrawal TP. Vitrectomy as a treatment for elevated intraocular pressure following intravitreal injection of triamcinolone acetonide. Am J Ophthalmol 2004;138:679-80.
24. Melamed S, Ben Simon GJ, Levkovitch-Verbin H. Selective laser trabeculoplasty as primary treatment for open-angle glaucoma: a prospective, nonrandomized pilot study. Arch Ophthalmol 2003;121:957-60.